Loading viewer...
investor_presentation
Format: PDF investor_presentation
Investor presentation for the proposed merger between Menlo Therapeutics and Foamix Pharmaceuticals to create a compelling dermatology combination. The combined company would leverage Foamix's FDA-approved topical minocycline, late-stage candidates, and proprietary Molecular Stabilizing Technology platform to address significant unmet needs in dermatology with indication-specific topical medicine innovation.
investor_presentation
17 Pages
Genesis Energy
investor_presentation
R1 RCM
Tanger Factory Outlet Centers 2024 Bridge Street Acquisition
investor_presentationinvestor_presentation
5 Pages
Tanger Factory Outlet Centers